CRISPR-Cas9: A potent gene-editing tool for the treatment of cancer

G Mishra, K Srivastava, J Rais, M Dixit… - Current Molecular …, 2024 - ingentaconnect.com
The prokaryotic adaptive immune system has clustered regularly interspaced short
palindromic repeat. CRISPR-associated protein (CRISPR-Cas) genome editing systems …

[HTML][HTML] Clonal expansion and myeloid leukemia progression modeled by multiplex gene editing of murine hematopoietic progenitor cells

X Shi, A Kitano, Y Jiang, V Luu, KA Hoegenauer… - Experimental …, 2018 - Elsevier
Highlights•We performed CRISPR/Cas9-mediated gene editing of a purified hematopoietic
stem cell (HSC) population.•Multiplex gene editing of HSCs causes clonal hematopoiesis …

CRISPR-Cas9 system: a novel and promising era of genotherapy for beta-hemoglobinopathies, hematological malignancy, and hemophilia

AM Alayoubi, ZY Khawaji, MA Mohammed… - Annals of …, 2024 - Springer
Gene therapy represents a significant potential to revolutionize the field of hematology with
applications in correcting genetic mutations, generating cell lines and animal models, and …

Progress and application of CRISPR/Cas technology in biological and biomedical investigation

J Lin, Y Zhou, J Liu, J Chen, W Chen… - Journal of Cellular …, 2017 - Wiley Online Library
Based on the tremendous progress of the understanding on the CRISPR‐Cas systems, the
application CRISPR/Cas technology has been extended into increasing scenarios in …

CRISPR/Cas9 editing of the genome for cancer modeling

A Guernet, L Grumolato - Methods, 2017 - Elsevier
The CRISPR/Cas9 revolution has democratized access to genome editing in many
biological fields, including cancer research. Cancer results from the multistep accumulation …

The potential revolution of cancer treatment with CRISPR technology

D Stefanoudakis, N Kathuria-Prakash, AW Sun, M Abel… - Cancers, 2023 - mdpi.com
Simple Summary Clustered regularly interspaced short palindromic repeats (CRISPR)-
CRISPR associated protein (Cas) 9 is a novel technology utilized to modify target genes …

[HTML][HTML] Genome editing in cancer: Challenges and potential opportunities

D Breier, D Peer - Bioactive Materials, 2023 - Elsevier
Ever since its mechanism was discovered back in 2012, the CRISPR/Cas9 system have
revolutionized the field of genome editing. While at first it was seen as a therapeutic tool …

[HTML][HTML] CRISPR/Cas: advances, limitations, and applications for precision cancer research

Y Yang, J Xu, S Ge, L Lai - Frontiers in medicine, 2021 - frontiersin.org
Cancer is one of the most leading causes of mortalities worldwide. It is caused by the
accumulation of genetic and epigenetic alterations in two types of genes: tumor suppressor …

Genome editing approaches with CRISPR/Cas9 for cancer treatment: Critical appraisal of preclinical and clinical utility, challenges, and future research

S Chira, A Nutu, E Isacescu, C Bica, L Pop, C Ciocan… - Cells, 2022 - mdpi.com
The increasing burden on human malignant diseases became a major concern for
healthcare practitioners, that must deal with tumor relapse and the inability to efficiently treat …

The rise of CRISPR/Cas for genome editing in stem cells

B Shui, L Hernandez Matias, Y Guo… - Stem cells …, 2016 - Wiley Online Library
Genetic manipulation is a powerful tool to establish the causal relationship between a
genetic lesion and a particular pathological phenotype. The rise of CRISPR/Cas9 genome …